Strengthening American Manufacturing Act of 2020

Bill: 116-hr-7677
Sponsor: full_name: Rep. Brindisi, Anthony [D-NY-22]
Introduced: 2020-07-20
Policy area: Armed Forces and National Security
Subjects: Appropriations

Buy American requirements

Cardiovascular and respiratory health

Congressional oversight

Defense spending

Department of Defense

Economic performance and conditions

Emergency medical services and trauma care

Executive agency funding and structure

Infectious and parasitic diseases

Manufacturing

Military procurement, research, weapons development

Public contracts and procurement
Latest action: action_date: 2020-07-20
text: Referred to the House Committee on Armed Services.

Summaries:
action_date: 2020-07-20
action_desc: Introduced in House
text: <p><b>Strengthening American Manufacturing Act of 2020</b></p> <p>This bill requires the Department of Defense (DOD) to report on its use of waivers with respect to requirements for buying certain articles only from U.S. sources (i.e, Buy American requirements).</p> <p>DOD must assess in its report the impact on the use of such waivers due to the COVID-19 (i.e., coronavirus disease 2019) pandemic.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 7677 IN THE HOUSE OF REPRESENTATIVES July 20, 2020 Mr. Brindisi (for himself and Mr. McKinley ) introduced the following bill; which was referred to the Committee on Armed Services A BILL To require the Secretary of Defense to submit to Congress a report on use of domestic nonavailability determinations, and for other purposes.

1. Short title This Act may be cited as the Strengthening American Manufacturing Act of 2020 . 2. Report on use of domestic nonavailability determinations Not later than September 30, 2021, and annually thereafter, the Secretary of Defense shall submit a report to congressional defense committees— (1) describing in detail the use of any waiver or exception by the Department of Defense to the requirements of chapter 83 of title 41, United States Code, or section 2533a of title 10, United States Code, relating to domestic nonavailability determinations; (2) specifying the type of waiver or exception used; and (3) providing an assessment of the impact on the use of such waivers or exceptions due to the COVID–19 pandemic and associated challenges with investments in domestic sources.